subscribe
 

‘Game-changing’ immunotherapy doubles head and neck cancer survival

Nivolumab became the first treatment to extend survival in a phase III clinical trial for patients with head and neck cancer in whom chemotherapy had failed



Cancer: ‘lifestyle’ vs ‘bad luck’ debate

Researchers have directly measured DNA errors in human adult stem cells from different organs



New biomarker can predict the course of childhood cancer

Protein discovered that can predict the course of neuroblastoma



Management of low-grade lymphoma

Australian, New Zealand and Canadian researchers pioneer world-first new standard of care for early stage lymphoma patients



Researchers have identified why cancer tumours resist drugs designed to 'starve' tumours

The findings demonstrate how cancer cells detect glucose levels and have the ability to survive with virtually no blood supply in the middle of a tumour mass



Gene testing in rare tumour type could uncover ‘cancer families’

Inherited cancer-causing mutations can give rise to the phenomenon of ‘cancer families’ where multiple family members develop cancer



Boost for bladder cancer detection

£500k funding for diagnosis and treatment technology at University of St Andrews



Starting gun fired in race against cancer evolution

New push against cancer to target disease’s ‘survival of the nastiest’; powerful computing aims to predict paths of cancer evolution; aim to discover new ‘anti-evolution’ therapies



Breast cancer: towards personalised treatment

Largest-ever study of breast cancer genomes reveals new genes and mutations involved in the disease



Immunotherapy is first to show survival benefit in head and neck cancer

Patients taking nivolumab were more than twice as likely to be alive after one year of the trial as those treated with chemotherapy



Cancer cells turn healthy cells to the 'dark' side

Researchers found that mutated KRAS also plays an important role in turning healthy ‘stromal cells’ into cancer’s allies



Cancer thwarts treatment by 'stealing' blood vessels

Cancers can resist treatment by ‘stealing’ blood vessels from nearby tissues, a new study shows



Children with cancer to get new gene test

Pilot study will sequence 81 cancer genes in children’s tumours to help personalise cancer treatment



Immune companion diagnostics

ImmunTraCkeR results on prediction of response to cancer immunotherapy selected for presentation at ASCO annual meeting



Success for the therapeutic vaccine for patients with cancer

Invectys opens up new hopes in cancer immunotherapy with vaccine INVAC-1



Non-invasive genomic bladder cancer profiling

Affymetrix receives grant for non-invasive genomic profiling of bladder cancer



Healthy cells 'collaborate' with tumours to help build new blood vessels

New study shows how healthy ‘collaborator’ cells build a beneficial environment around tumours to help cancer grow



Ecologically diverse breast cancers more likely to be deadly

Scientists develop test which combines methods used by ecologists with a cancer imaging technique to pick out cancerous cells from normal cells in tumours



So-called junk DNA plays role in preventing breast cancer

Supposed ‘junk’ DNA, found in between genes, plays a role in suppressing cancer, according to new research by Universities of Bath and Cambridge



‘Junk’ DNA plays role in preventing breast cancer

Supposed ‘junk’ DNA, found in between genes, plays a role in suppressing cancer, according to new research by Universities of Bath and Cambridge



Pages

Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe